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The intraﬂagellar transport (IFT) complex is essential for the formation and functional maintenance
of eukaryotic cilia which play a vital role in development and tissue homeostasis. However, the bio-
chemical characteristics and precise functions of IFT proteins remain unknown. Here, we report that
MIP-T3, a human microtubule-interacting protein recently identiﬁed as a novel conserved compo-
nent of the IFT complex, is an easily degradable protein in human cell lines. Protein degradation
is mediated by the ubiquitin–proteasome system, and the C-terminus is required for ubiquitination
and proteasome-mediated degradation of MIP-T3 protein. This study provides the ﬁrst evidence for
regulation of IFT protein stability.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MIP-T3 (microtubule-interacting protein associated with
TRAF3), also termedas TNFReceptor-Associated Factor 3 Interacting
Protein 1 (TRAF3IP1), has been ﬁrst identiﬁed as a human protein
that binds to tubulin/microtubules and TRAF3 [1], IL-13 receptor al-
pha1 [2], and Disrupted-in-Schizophrenia 1 (DISC 1) [3]. Recently,
several genome- and proteome-wide studies in different organisms
havedemonstrated thatMIP-T3/TRAF3IP1 is anovel conserved com-
ponent of intraﬂagellar transport (IFT) complex, which is essential
for the formation and functional maintenance of eukaryotic cilia
[4–8], and more intriguingly, IFT system has recently been demon-
strated that is expressed in non-ciliated hematopoietic cells, and
plays an important role in immune synapse assembly and intracel-
lular membrane trafﬁcking in T lymphocytes [9]. Additionally, our
proteomic study has recently demonstrated that MIP-T3 can inter-
act with different cytoskeletal proteins, chaperones, and signalingchemical Societies. Published by E
cular Pharmacology of Infec-
and Immunology, Graduate
-14 Bunkyo-Machi, Nagasaki
to).proteins, suggesting MIP-T3 may be an important protein involved
in several cellular processes [10].
Cilia are highly conserved microtubule-based organelles that
protrude from the surface ofmost eukaryotic cells. Cilia play diverse
roles in cellular motility, sensory transduction and signaling pro-
cesses critical in regulating vertebrate development and tissue
homeostasis [11]. Defects in cilia structure or function lead to awide
range of humandiseases anddevelopmental disorders (ciliopathies)
[12]. Accordingly, it can be considered that regulation of IFT protein
stability is a key step in controlling the structure and function of
cilia. Selective protein degradation is crucial for regulating a variety
of basic cellular processes, including the control of cell signaling,
regulation of cell cycle and division, modulation of the immune
and inﬂammatory responses, and development and differentiation
[13,14]. Rapid removal of cellular proteins is an important regula-
tory mechanism that can tightly control the expression and activity
of a protein in eukaryotic cells. Thus, studying the degradation of IFT
protein canprovide valuable insights into understanding the regula-
tion and cellular function of the protein.
In this study, we investigated the stability of MIP-T3 protein in
several human cell lines and found that MIP-T3 protein level is
highly regulated; mainly mediated by the ubiquitin–proteasome
system (UPS), and the C-terminal region is required for the UPS-
mediated degradation of MIP-T3 protein.lsevier B.V. All rights reserved.
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2.1. Cell cultures
HEK293 and A549 cells were grown in DMEM (Invitrogen), HeLa
cells were cultured in MEM (Invitrogen), and HSC-2 cells were
maintained in MEM alpha (Invitrogen). All of the media were sup-
plemented with 10% fetal bovine serum and 1% penicillin/
streptomycin.
2.2. Plasmid constructs, antibodies and reagents
Plasmids encoding human MIP-T3 gene and its deletion mu-
tants, CL(aa211-625), C(aa411-625) and NL(aa1-410), were gener-
ated by the polymerase chain reaction (PCR) using DNA
polymerase KOD plus (TOYOBO), and then sub-cloned into pCAGGS
or pEGFP-C1 vectors. Each plasmid DNAwas puriﬁed by PureLink™
HiPure Filter Plasmid Kit (Invitrogen) according to the manufac-
turer’s instructions, and conﬁrmed by restriction mapping and
DNA sequencing. Guinea pig polyclonal antibody against MIP-T3
was generated as described previously [10]. Goat polyclonal anti-
MIP-T3 antibody (Santa cruz), Rabbit monoclonal anti-b-actin anti-
body (Epitomics) and rabbit polyclonal anti-GFP antibody (MBL)
were commercially purchased. MG132 was purchased from Calbio-
chem, and E64D, 3-Methyladenine (3-MA), and cycloheximide
(CHX) were purchased from Sigma–Aldrich.
2.3. RT-PCR
For RT-PCR analysis, cells were dissolved by TRIzol LS reagent
(Invitrogen), and total RNA was extracted. One microgram of total
RNAwas then reverse transcribedwith TranscriptorUniversal cDNA
master (Roche) using randomhexamer primers.MIP-T3 andGAPDH
were respectively ampliﬁedbyPCRusing the followingprimers: for-
ward, 50-CCTGAAAGAACAAACGAGCTGCTCC-30; and reverse, 50-
GTGAACTCTGGACTCTTCTTCTCGC-30, for MIP-T3 (expected length
of product: 186bp); forward, 50-AAGGTCGGAGTCAACGGATT-30;
and reverse, 50-CTGGAAGATGGTGATGGGATT-30, for GAPDH (ex-
pected length of product: 222bp). The PCR was performed with
the following conditions: 30 cycles of 95 C for 15 sec and 65 C for
1 min. Fivemicroliters of each RT-PCR product was electrophoresed
on a10%polyacrylamide gel followedby ethidiumbromide staining.
2.4. Western blotting and immunoprecipitation
Cells were lysed and analyzed by Western blotting as described
previously [10]. Beta-actin or alpha-tubulin was used as a loading
control. Proteins were visualized by ECL detection reagent (GE
Healthcare Biosciences). The protein level was determined by scan-
ning of band intensity and analyzedusing the IMAGEJ software (NIH).
For immunoprecipitation of ectopically expressed MIP-T3, a to-
tal of 5  106 HeLa cells were transiently transfected with 10 lg of
pCAGGS-MIP-T3 plasmid using Lipofectamine 2000 (Invitrogen)
for 24 h, then treated with MG132 (25 lM) or DMSO (vehicle con-
trol) for further 12 h, subsequently performed immunoprecipita-
tion as described previously [10]. Proteins were separated by 10%
SDS-PAGE, blotted on PVDF membranes and analyzed by Western
blotting. Ubiquitinated proteins were detected using mouse anti-
mono- and poly-ubiquitinylated conjugate antibody (FK2H) (Enzo
Life Sciences).
2.5. Analysis of protein stability
Cells were seeded in 24-well plate, transfected with 1 lg of
pCAGGS-MIP-T3 per well, and then incubated at 37 C for 24, 48,72 and 96 h. Cells were harvested at the indicated time points,
lysed and subjected to 10% SDS-PAGE, and analyzed by Western
blotting using anti-MIP-T3 antibody and anti-b-actin antibody.
To analyze the stability of MIP-T3 protein and its truncation
mutants, A549 cells were transiently transfected with MIP-T3 or
its mutants for 18 h, then further treated with CHX (100lg/ml)
for 3, 6, 12, 18, 24 and 30 h, respectively. Cells were lysed at the
indicated time points and analyzed by Western blotting.
To examine the effect of MG132, E64D or 3-MA on degradation
of MIP-T3 protein, MIP-T3-transfected A549 cells were treated
with CHX (100 lg/ml) combined with a range of concentrations
of MG132 (5–50 lM), E64D (25–200 lM) or 3-MA (5–25 mM) for
18 h, respectively, and then analyzed by Western blotting.3. Results
3.1. Ectopically expressed MIP-T3 is rapidly degraded in human cells
Since MIP-T3 mRNA has been demonstrated that is ubiquitously
expressed in all of the tested tissues and cell lines in previous re-
port [1], we ﬁrst conﬁrmed the mRNA and protein expression level
of MIP-T3 in A549, HeLa and HSC-2 cells in this study. We found
that the intrinsic MIP-T3 protein was hardly detected by Western
blotting using speciﬁc anti-MIP-T3 antibody, although MIP-T3
mRNA is normally detectable (Fig. S1). These results suggest that
steady-state level of MIP-T3 protein is kept extremely low or
unstable in these human cell lines. Furthermore, we found that
exogenously expressed MIP-T3 protein was rapidly decreased from
48 h, and disappeared at 96 h after transfection (Fig. 1A and B).
To conﬁrm whether the degradation of MIP-T3 protein is due to
the reduction of mRNA level, we investigated the MIP-T3 mRNA le-
vel using a semi-quantitative RT-PCR analysis. As shown in Fig. 1C
and 1D, there was no signiﬁcant time-dependent change in MIP-T3
mRNA expression in the transfected cells, suggesting the reduction
of MIP-T3 protein was due to protein degradation rather than the
change of mRNA level.
To further deﬁne the protein degradation is attributed to its
protein nature, we compared the expression of GFP-fused MIP-T3
to GFP protein in human cells after transfection. As shown in
Fig. 1E, GFP-fused MIP-T3 expressing cells were time-dependently
reduced, but the GFP-expressing cells remain unchanged during
96 h of transfecion. In addition, co-transfection of GFP and GFP-
MIP-T3 also demonstrated that only GFP-MIP-T3 was speciﬁcally
degraded in a time-dependent manner (Fig. 1F). These results
strongly suggest that MIP-T3 is a relatively easily degradable pro-
tein in these cells.
3.2. Degradation of MIP-T3 is mediated by ubiquitin/proteasome
pathway
Generally, protein degradation in eukaryote cells is mediated by
two major pathways, ubiquitin–proteasome pathway and autoph-
agy–lysosome pathway [15]. To determine which proteolytic path-
way is responsible for MIP-T3 degradation in human cell lines, we
tested several protease inhibitors for their inhibitory effects on
MIP-T3 protein degradation in A549 cells. As shown in Fig. 2A,
treatment with the proteasome inhibitor MG132 restored the
expressing level of MIP-T3 protein. In contrast, the cysteine prote-
ase inhibitor E64D, which inhibits calpain and lysosomal proteases,
had no signiﬁcant effect on MIP-T3 protein degradation. Interest-
ingly, 3-Methyladenine (3-MA), an autophagy inhibitor, could par-
tially rescue MIP-T3 protein degradation.
We further performed a CHX-chase assay by the addition of
CHX combined with different concentrations of MG132, E64D
and 3-MA to log-phase cultures followed by lysis at the indicated
Fig. 1. Time-dependent degradation of MIP-T3 protein in different human cells. (A) Western blot analysis for expressions of MIP-T3 and b-actin in A549, HeLa and HSC-2 cells,
which was transiently transfected with pCAGGS-MIP-T3 for 24, 48, 72 and 96 h, respectively. (B) Relative percentage of MIP-T3 level was time-dependently decreased during
96 h of transfection. (C) Total cellular RNA was extracted from transfected cells, and the mRNA levels of MIP-T3 and GAPDH were respectively analyzed by RT-PCR. (D) No
signiﬁcant time-dependent changes in the MIP-T3 mRNA level was observed from 24 to 96 h after transfection (E) Fluorescence microscopic observations of GFP and GFP-
fused MIP-T3 expressed in A549 cells at the indicated time point after transfection. (F) Western blot analysis for GFP, GFP-fused MIP-T3, and b-actin in A549 cells at the
indicated time point after co-transfection.
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with E64D effectively inhibited MIP-T3 protein degradation in a
dose-dependent manner. Whereas, 3-MA only partially inhibited
the degradation treated at high concentration (Fig. 2D). These re-
sults suggest that MIP-T3 protein degradation is mainly mediated
by proteasome degradation pathway.
Since polyubiquitination of protein is essential for proteasome-
mediated proteolysis, we further conﬁrmed that the effect of
MG132 treatment on accumulation of polyubiquitinated cellular
proteins. As shown in Fig. 2E, total polyubiquitinated proteins in-
creased in the MG132-treated HeLa cells. Furthermore, immuno-
precipitation experiment demonstrated that MIP-T3 protein level
was increased by MG132 treatment (Fig. 2F), in which polyubiqui-
tinated proteins were also accumulated (Fig. 2G).
3.3. Endogenous MIP-T3 degradation is also mediated by ubiquitin/
proteasome pathway
To investigate whether the endogenous MIP-T3 is also easily de-
graded in human cells, we ﬁrst examined the turnover of endoge-
nous MIP-T3 by a CHX chase analysis combined with
immunoprecipitation experiment. As showed in Fig 3A and B, after
inhibition of protein synthesis by CHX treatment, the immunopre-
cipitated endogenous MIP-T3 protein level decreased in a time-
dependentmanner, suggesting that the endogenousMIP-T3 protein
is rapidly degraded in these human cells.
We further conﬁrmed the effects of MG132 on accumulation of
endogenous MIP-T3 by a Western blotting/immunoprecipitation
analysis. As shown in Fig. 3C, although the total polyubiquitinated
proteins signiﬁcantly accumulated in MG132-treated cells, but the
endogenous MIP-T3 is still hardly detectable by Western blotting.Whereas, after enrichment by immunoprecipitation with anti-
MIP-T3 antibody, the intrinsic MIP-T3 protein could be detected
and was time-dependently increased following MG132 treatment,
accompanying the increased levels of total polyubiquitinated pro-
tein in the cells (Fig. 3D). Taken together, these results demon-
strated that the proteasome inhibition increased endogenous
MIP-T3 protein level as well as elevated level of polyubiquitinated
proteins, suggesting the intrinsic MIP-T3 protein degradation may
be also mediated by ubiquitin/proteasome pathway.
3.4. The C-terminus of MIP-T3 protein is crucial for its degradation
To determine if there are conserved regions in MIP-T3 protein
responsible for protein degradation and ubiquitination, we con-
structed several truncation mutants of MIP-T3 (Fig. 4A), and ex-
pressed them in HeLa cells (Fig. 4B). As shown in Fig. 4C, after
CHX treatment, the expression levels of MIP-T3 and the mutants
with the C-terminus (MIP-T3-CL and MIP-T3-C) signiﬁcantly re-
duced in a time-dependent manner. In contrast, the mutant lacking
C-terminal 215 amino acids (MIP-T3-NL) displayed resistance to
degradation. The estimated half-life of exogenously expressed
MIP-T3, MIP-T3-CL and MIP-T3-C protein were 21.7±2.7, 14.8±1.1
and 17.8±6.6 h, respectively, but that of MIP-T3-NL was 115 h
(Fig. 4D), indicating that the C-terminal region (residues
411  625) is crucial for mediating MIP-T3 protein degradation.
3.5. The C-terminal region of MIP-T3 is required for its ubiquitination
To further conﬁrm if the C-terminal region was required for
ubiquitination of MIP-T3 protein, we expressed GFP-fused MIP-
T3 (pEGFP-MIP-T3) and the GFP-fused truncation mutants in HeLa
Fig. 2. MIP-T3 protein degradation was mediated by ubiquitin–proteasome pathway. (A) Effects of various inhibitors treatment on MIP-T3 protein degradation. A549 cells
were transiently transfected with pCAGGS-MIP-T3 and treated with various protease inhibitors, MG132 (25 lM), E64D (25 lM) and 3-MA (10 mM) for the indicated period.
DMSO was used as a vehicle control. (B) Dose-dependent effects of MG132 (5–50 lM) on MIP-T3 degradation. (C) Effects of E64D (25–200 lM) on MIP-T3 degradation. (D)
Effects of 3-MA (5–25 mM) on MIP-T3 degradation. (E) Total cellular polyubiquitinated proteins are accumulated following 12 h of treatment with MG132 (25 lM) and DMSO
(0.1% v/v, vehicle control). (F and G) MIP-T3 protein level increased in MG132-treated cells. Immunoprecipitation/Western blot analyses showed that MIP-T3 protein was
polyubiquitinated in MG132-treated cells. The asterisk indicates IgG heavy chain, and the bracket indicates polyubiquitinated proteins.
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As shown in Fig 5A, GFP-fused MIP-T3 and its mutants were immu-
noprecipitated, respectively (upper panel). Wild-type MIP-T3, MIP-
T3-CL and MIP-T3-C variants appeared to have signiﬁcantly higher
level of polyubiquitination than MIP-T3-NL (lower panel). More-
over, the relative ratios of bound polyubiquitinated proteins to
GFP-MIP-T3 and its mutants were calculated respectively and sum-
marized in Fig. 5B, deletion of C-terminal region of MIP-T3 (resi-
dues 411 and 625) abolished polyubiquitination of MIP-T3,
suggesting the C-terminal is crucial for its polyubiqutination.4. Discussion
Recently, the ubiquitin–proteasome system (UPS) has been re-
ported to be involved in the disassembly of cilia and ﬂagella. Dur-
ing ciliary resorption, the ubiquitin conjugation system is present
in cilia and adds an ubiquitin tag to axonemal turnover and break-
down products such as alpha-tubulin, which are transported by
retrograde IFT complex to the cell body and can be reutilized in
making new cilium [16]. However, whether the IFT proteins are
also ubiquitinated during shortening process and the fates of these
IFT proteins after ciliary resorption is still unclear. In mammalian
cells, cilia and ﬂagellar disassembly (also called resorption or
shortening) occurs normally in synchrony with the cell cycle. Cilia
must be removed before cell’s entry into mitosis perhaps becausethe ciliary basal body must be freed from the cilium to become
the centriole that helps form the mitotic spindle [17]. The present
study for the ﬁrst time showed that endogenously, or ectopically
expressed MIP-T3 protein is indeed ubiquitinated and degraded
via proteasome pathway in human cells, indicating the UPS may
be involved in the regulation of IFT protein stability.
Notably, the C-terminal truncation inhibited the degradation
and polyubiquitination of MIP-T3 protein, suggesting the C-termi-
nus is required for its proteasomal degradation and polyubiquiti-
nation of MIP-T3. In most proteins, the preferred acceptor site for
polyubiquitin chain addition is a lysine side chain. MIP-T3 se-
quence analysis conﬁrmed that the C-terminus of MIP-T3 contains
rich lysine residues, supporting the possibility that the major ubiq-
uitin conjugation site is localized in the C-terminus of MIP-T3. Fur-
thermore, the C-terminus also contains conserved coiled-coil
domain, a protein–protein interacting interface [1], which is con-
served in a number of IFT proteins (IFT81, IFT74/72, IFT57/55 and
IFT20) [18]. Therefore, it is also possible the site is required for
polyubiquitination mediated by E3 ubiquitin ligases, although the
role of the conserved coiled-coil domain on regulation of IFT pro-
tein stability was not clariﬁed in this study.
Moreover, multiple chaperone-assisted degradation pathways
including CAP (chaperone-assisted proteasomal degradation),
CASA (chaperone-assisted selective autophagy), and CMA (chaper-
one-mediated autophagy) have also been reported [19]. Within
these pathways chaperones facilitate the sorting of non-native
Fig. 3. Intrinsic MIP-T3 degradation was mediated by ubiquitin–proteasome pathway. (A) CHX-chase analysis of the intrinsic MIP-T3 turnover. Intrinsic MIP-T3 protein in
DMSO or CHX treated HeLa cells were immunoprecipitated at the indicated time point and subject to Western blot analysis using anti-MIP-T3 antibody. Alpha-tubulin in each
cell lysate was also detected as the loading control. (B) Relative percentage of the amount of intrinsic MIP-T3 protein normalized by a-tubulin protein level at the indicated
time point relative to that at 0 h. Error bars indicate mean values ± SD from three independent experiments. (C) Accumulation of the ubiquitinated proteins in HeLa cells
which were treated with or without MG132 at 25 lM for 6 and 12 h. Total cell lysates were prepared, and 1% of input was analyzed by Western blotting. (D) The remaining
lysates were analyzed by immunoprecipitation/Western blotting. MG132 treatment time-dependently increased the accumulation of endogenous MIP-T3 proteins as well as
the elevated level of polyubiquitinated proteins. Ubn indicates polyubiquitinated proteins.
Fig. 4. C-terminal region was crucial for degradation of MIP-T3 protein in cells (A) The schematic representation of MIP-T3 and its truncation mutants. (B) Western blot
analysis of expressions of MIP-T3 and its mutants in A549 cells at 24 h post-transfection. (C) Expressions of MIP-T3 and its mutants in A549 cells treated with CHX (100 lg/
mL) for the indicated period after 18 h of transfection. (D) The estimated half-life of each protein was showed. Data were presented as the means ± S.D. of three independent
experiments. The asterisks indicate signiﬁcant differences in protein expressing levels between the MIP-T3 NL and the others, ⁄P < 0.05, ⁄⁄P < 0.01.
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Fig. 5. C-terminal region of MIP-T3 was required for ubiquitination. (A) HeLa cells were transfected with pEGFP, GFP-MIP-T3 and its GFP-tagged truncation mutants for 24 h,
respectively, and treated with MG132 for a further 12 h, and then immunoprecipitated with polyclonal anti-GFP antibody. The immunoprecipitates were analyzed by
Western blotting using anti-GFP (upper panel) and anti-ubiquitin (lower panel) antibodies. Ubn indicates polyubiquitinated proteins. The closed arrowheads indicate the
position of each protein. (B) The relative ratio of bound multi-ubiquitinated proteins to GFP-MIP-T3 and its mutants. The asterisks indicate signiﬁcant differences in relative
protein levels between the MIP-T3 NL and the others, ⁄P < 0.05, ⁄⁄P < 0.01.
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represent an essential aspect of cellular proteostasis. Since our pre-
vious study demonstrated MIP-T3 can interact with chaperones,
including heat shock protein 90 (HSP90), heat shock 70 kDa pro-
tein (HSP70), heat shock cognate 71 kDa protein (Hsc70), whether
the interaction between MIP-T3 and these chaperones might con-
tribute to its stability regulation via chaperone-assisted degrada-
tion needs further study. The present results show that 3-MA
treatment had partial inhibitory effect on the MIP-T3 protein deg-
radation, thus the CMA pathway may also partially involve in the
degradation of exogenously expressed MIP-T3. However, more re-
cently, 3-MA, the most commonly used pharmacologic inhibitor of
autophagy, has been shown that has dual role in modulation of
autophagy, there are marked increases of the autophagic markers
in cells treated with 3-MA in full medium for a prolonged period
of time (up to 9 h), especially when used at high concentrations
[20]. Therefore, the underlying mechanism of 3-MA treatment on
MIP-T3 protein degradation needs further experiments to
elucidate.
In conclusion, the present study revealed that MIP-T3 protein
level in different human cell lines is regulated via the ubiquitin–
proteasome degradation pathway. The C-terminal region of MIP-
T3 is required for ubiquitination and the proteasome-dependent
degradation of MIP-T3. This study provides the ﬁrst evidence for
regulation of IFT protein stability.Acknowledgements
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